Genome-wide analysis identifies an african-specific variant in SEMA4D associated with body mass index
- PMID: 28296344
- PMCID: PMC5373947
- DOI: 10.1002/oby.21804
Genome-wide analysis identifies an african-specific variant in SEMA4D associated with body mass index
Abstract
Objective: The prevalence of obesity varies between ethnic groups. No genome-wide association study (GWAS) for body mass index (BMI) has been conducted in continental Africans.
Methods: We performed a GWAS for BMI in 1,570 West Africans (WA). Replication was conducted in independent samples of WA (n = 1,411) and African Americans (AA) (n = 9,020).
Results: We identified a novel genome-wide significant African-specific locus for BMI (SEMA4D, rs80068415; minor allele frequency = 0.008, P = 2.10 × 10-8 ). This finding was replicated in independent samples of WA (P = 0.013) and AA (P = 0.017). Individuals with obesity had higher serum SEMA4D levels compared to those without obesity (P < 0.0001), and elevated levels of serum SEMA4D were associated with increased obesity risk (OR = 4.2, P < 1 × 10-4 ). The prevalence of obesity was higher in individuals with the CT versus TT genotypes (55.6% vs. 22.9%).
Conclusions: A novel variant in SEMA4D was significantly associated with BMI. Carriers of the C allele were 4.6 BMI units heavier than carriers of the T allele (P = 0.0007). This variant is monomorphic in Europeans and Asians, highlighting the importance of studying diverse populations. While there is evidence for the involvement of SEMA4D in inflammatory processes, this study is the first to implicate SEMA4D in obesity pathophysiology.
© 2017 The Obesity Society.
Figures
References
-
- Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet. 1997;27:325–351. - PubMed
-
- Chen G, Adeyemo AA, Johnson T, Zhou J, Amoah A, Owusu S, et al. A genome-wide scan for quantitative trait loci linked to obesity phenotypes among West Africans. Int J Obes (Lond) 2005;29:255–259. - PubMed
MeSH terms
Substances
Grants and funding
- HHSN268201100012C/HL/NHLBI NIH HHS/United States
- HHSN268201100009I/HL/NHLBI NIH HHS/United States
- N01 HC095161/HL/NHLBI NIH HHS/United States
- HHSN268201100010C/HL/NHLBI NIH HHS/United States
- HHSN268201100007C/HL/NHLBI NIH HHS/United States
- HHSN268201100011I/HL/NHLBI NIH HHS/United States
- U01 HG004402/HG/NHGRI NIH HHS/United States
- HHSN268201100005I/HL/NHLBI NIH HHS/United States
- N01 HC095163/HL/NHLBI NIH HHS/United States
- N01 HC095166/HL/NHLBI NIH HHS/United States
- N01 HC095162/HL/NHLBI NIH HHS/United States
- N01 HC095160/HL/NHLBI NIH HHS/United States
- N01 HC095168/HL/NHLBI NIH HHS/United States
- U54 HG006947/HG/NHGRI NIH HHS/United States
- ZIA HG200362/ImNIH/Intramural NIH HHS/United States
- R01 HL046380/HL/NHLBI NIH HHS/United States
- D43 TW009106/TW/FIC NIH HHS/United States
- HHSN268201100008C/HL/NHLBI NIH HHS/United States
- N02 HL064278/HL/NHLBI NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- HHSN268201100005G/HL/NHLBI NIH HHS/United States
- HHSN268201100008I/HL/NHLBI NIH HHS/United States
- HHSN268201100011C/HL/NHLBI NIH HHS/United States
- UL1 RR024156/RR/NCRR NIH HHS/United States
- HHSN268201300048C/HL/NHLBI NIH HHS/United States
- N01 HC095167/HL/NHLBI NIH HHS/United States
- Z01 DK054001/ImNIH/Intramural NIH HHS/United States
- HHSN268201100006C/HL/NHLBI NIH HHS/United States
- HHSN268201300049C/HL/NHLBI NIH HHS/United States
- HHSN268201300047C/HL/NHLBI NIH HHS/United States
- T37 TW000041/TW/FIC NIH HHS/United States
- HHSN268201300050C/HL/NHLBI NIH HHS/United States
- HHSN268201100009C/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
- HHSN268201100007I/HL/NHLBI NIH HHS/United States
- HHSN268201300046C/HL/NHLBI NIH HHS/United States
- N01 HC065226/HL/NHLBI NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
- N01 HC095164/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
